HDSI Project
Implementation of Point-of-Care Pharmacogenomic Decision Support In Postoperative Pain Management
Effective pain control without undue toxicity stands as one of the single most important addressable healthcare challenges. Pharmacogenomics is the study of genetic factors governing drug response and toxicity. Our goal for this application is to overcome barriers to effective and safe analgesic management by instituting and studying an operational implementation to deliver genomic information at the point-of-care to permit genomic-informed pain medication prescribing.
David Dickerson, MD, Peter O’Donnell, MD, supported by a multidisciplinary team.,